Try our Advanced Search for more refined results

August 17, 2011

Sandoz Inc. v. Novo Nordisk, Incorporated et al

Track this case

Case Number:

2:11-cv-13594

Court:

Michigan Eastern

Nature of Suit:

Patent

Judge:

Avern Cohn

Firms

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. August 18, 2011

    Sandoz Wants Novo's Prandin Patent Ruled Invalid Again

    Generic-drug maker Sandoz Inc. filed a suit Wednesday in Michigan federal court seeking to have Novo Nordisk Inc.'s patent protecting the diabetes drug Prandin declared — for a second time — invalid and unenforceable.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!